Therefore, it can be seen that FADD is most likely to play a role in the chemotherapy resistance of hypopharyngeal cancer, which is quite consistent with the conclusion drawn by our proteomics, which also fully arouses our interest in FADD. The gene discussed is FADD; the disease is hypopharynx cancer.